Enhanced Sternal Closure With Montage or Montage-CT to Evaluate Post-Operative Opioid Use Following Median Sternotomy

Exclusion Criteria

• •1. Recent CPR.
• •2. Previous cardiac surgery (redo sternotomy).
• •3. Emergency surgery (operative intervention within 24 hrs of assessment).
• •4. Chronic lung disease.
• •5. BMI \> 40.
• •6. Use of sternal plate systems for closure.
• •7. Recent antiplatelet therapy.
• •8. Previous radiotherapy to the chest; receiving immunosuppressive therapy or have a current immunosuppressive condition.
• •9. Active systemic infection (.i.e: endocarditis).
• •10. Cognitive impairment (confusion, dementia, Alzheimers, current substance abuse).
• •11. History of malignancies within past year (except squamous or basal cell carcinoma of the skin that has been treated; no recurrence)
• •12. Recent history of drug or alcohol abuse.
• •13. Females who are pregnant, nursing or of childbearing potential who are not practicing a birth control method with high reliability.
• •14. Postsurgical life expectancy \< 90 days in the opinion of the investigator.
• •14\. Moderate or severe pectus deformity. 16. Participation in another clinical trial. 17. Patients who had Patient-Controlled Analgesia (PCA) devices after surgery. 18. Patients who received a local anesthetic treatment and/or device on the sternum intraoperatively during surgery (e.g. On-Q Pain Relief System, Exparel etc)